Daiichi Sankyo Company, Limited
Sumitomo Dainippon Pharma Co., Ltd. Notice on the Disposal of Treasury Stock in connection with Mid-Term Earnings-Linked Stock-Based Compensation for Directors, etc.
As part of the mid-term earnings-linked stock-based compensation, 701,100 shares will be disposed of at 2,614 yen per share. Planned for August 6, 2026. Dilution is 0.04%; disposal is conducted via a trust, with no immediate market outflow anticipated; the trust agreement is to be extended to the end of August 2031.
Key Figures
- Disposed shares: 701,100 shares
- Disposal price: 2,614 yen/share
- Total disposal amount: 1,832,675,400 yen
- Dilution: 0.04%
- Eligible period: 2026 fiscal year to 2030 fiscal year
AI要約
Overview
Sumitomo Dainippon Pharma has approved by the Board of Directors a disposal of treasury stock accompanied by a partial revision of the mid-term earnings-linked stock-based compensation plan. The対象 period spans five fiscal years from 2026 to 2030, including expansion of eligibility to foreign nationals and non-residents, and additional treasury stock disposal. This will be implemented under a trust contract through a joint-entrustee arrangement, with the disposed shares not expected to involve market outflow.
Impact and Background
Total disposal amount is approximately 1,832.7 million yen, with dilution to total issued shares estimated at 0.04%, a small impact. The trust agreement is scheduled to commence on March 7, 2025, and extend to the end of August 2031. Independent third-party opinions were deemed unnecessary. The disposal price is set based on the closing price prior to the Board resolution, and the statutory auditors have not regarded this as a particularly advantageous price.
Sumitomo Dainippon Pharma Co., Ltd.
Company overview · Stock price · Financial data · All IR
